Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis

Author(s): Mahsa Hajivalili, Fatemeh Pourgholi, Hossein Samadi Kafil, Farhad Jadidi-Niaragh, Mehdi Yousefi

Journal Name: Current Stem Cell Research & Therapy

Volume 11 , Issue 1 , 2016

Become EABM
Become Reviewer
Call for Editor


Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder which is characterized by motor neuron (MN) dysfunction, progressive paralysis, and death. Although several therapeutic approaches have been used for treatment of ALS, little success has been achieved. Natural vectors such as mesenchymal stem cells (MSCs) can be a promising tool for overcoming therapeutic problems. MSCs have multipotential characteristics such as the ability to differentiate into variety of cell types, easy access, immunomodulation, tissue repair, exertion of trophic factors, exosome secretion and efficient homing. In this review, we will discuss the characteristics of MSCs and their possible therapeutic mechanisms in ALS patients.

Keywords: Amyotrophic lateral sclerosis, mesenchymal stem cells, stem cell, treatment.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 08 January, 2016
Page: [41 - 50]
Pages: 10
DOI: 10.2174/1574888X10666150902095031

Article Metrics

PDF: 122